NFKB1 and diabetes mellitus: In addition to the well-established role of NF-κB in both immunity and inflammation, deregulation of NF-κB signaling is associated with cancer malignancies, diabetes, and atherosclerosis, further emphasizing the wide spectrum of roles it plays in control of normal growth, tissue homeostasis, and diseases [3], [4], [5].